Former Chief Operating Officer · Neurogene Inc. (NGNE)

Lloyd Mackenzie

FY2018 is the first fiscal year CompBrief holds for Lloyd Mackenzie as a named executive officer of Neurogene; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,937,439

Salary $380,442Stock awards $0

2nd of 3 named executive officers at Neurogene by FY2018 total.

3 named officers on file for Neurogene, FY2018

Lloyd Mackenzie’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Neurogene’s whole pay program stands against its peers

  • Neurogene’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NGNE→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 2, 2019 (DEF 14A).

Free

Get Lloyd Mackenzie’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Lloyd Mackenzie compensation by year

Neurogene Summary Compensation Table · the one fiscal year held
In US dollars, as Neurogene reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$380,442
Bonus$0
Stock awards$0
Option awards$1,152,576
Non-equity incentive$127,750
Pension and deferred compensation$0
All other$276,671
Total$1,937,439

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Neurogene Inc. DEF 14A filed October 2, 2019, accession 0001193125-19-260378, and prior-year filings.

How this page was built: the Neurogene Inc. filed document, accession 0001193125-19-260378. Every figure is read from that document and cited to the page and table it appears in. Filed October 2, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option145,000—$3.07

Per the Outstanding Equity Awards at Fiscal Year-End table in Neurogene Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

Neurogene’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
David MainFormer Chief Executive Officer and President$4,226,286
Lloyd Mackenzie · this pageFormer Chief Operating Officer$1,937,439
Kamran AlamInterim Chief Financial Officer and Vice President, Finance$1,755,527

The full Neurogene compensation record

free company brief

This page is one person within Neurogene's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Neurogene's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Lloyd Mackenzie's compensation dossier · One-time report. No refunds.